IDEAS home Printed from https://ideas.repec.org/a/ags/aesjfr/405204.html

The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation

Author

Listed:
  • Phelan, Martha
  • Kerins, David

Abstract

Obesity is a major risk factor for cardiovascular disease (CVD). Lipid abnormalities, hypertension, impaired glucose tolerance or diabetes, are cardiovascular risk factors that are frequently present in patients with obesity. Haemostatic and fibrinolytic disturbances are also considered to be important risk factors for CVD hence, a potential link between CVD, obesity and the metabolic syndrome arises. Regulation of the fibrinolytic system can occur at the level of plasminogen activators and plasminogen activator inhibitor-1 (PAI-1). PAI-1, a glycoprotein, is one of the most important inhibitors of fibrinolysis. Regulation of this serine protease inhibitor may have a beneficial effect on other conditions associated with the metabolic syndrome. Human adipose tissue is a source of PAI-1. PAI-1 production may in turn be controlled by a number of hormones and cytokines which are secreted by adipose tissue in addition to dietary factors. In this review we summarise the current knowledge regarding the role of altered fibrinolytic function in obesity, CVD and hence the metabolic syndrome. Regulatory factors including different dietary components, weight loss and dietary intervention will also be discussed.

Suggested Citation

  • Phelan, Martha & Kerins, David, 2014. "The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation," Journal of Food Research, Canadian Center of Science and Education, vol. 3(6).
    • Handle: RePEc:ags:aesjfr:405204
    as

    Download full text from publisher

    File URL: https://ageconsearch.umn.edu/record/405204/files/38252-133877-3-PB.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Claire M. Steppan & Shannon T. Bailey & Savitha Bhat & Elizabeth J. Brown & Ronadip R. Banerjee & Christopher M. Wright & Hiralben R. Patel & Rexford S. Ahima & Mitchell A. Lazar, 2001. "The hormone resistin links obesity to diabetes," Nature, Nature, vol. 409(6818), pages 307-312, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Park, Hyun Joon & Francisco, Sara Chari & Pang, M. Rosemary & Peng, Lulu & Chi, Guangqing, 2023. "Exposure to anti-Black Lives Matter movement and obesity of the Black population," Social Science & Medicine, Elsevier, vol. 316(C).
    2. Wu, Hania Fei, 2021. "Social determination, health selection or indirect selection? Examining the causal directions between socioeconomic status and obesity in the Chinese adult population," Social Science & Medicine, Elsevier, vol. 269(C).
    3. Wen Kong & Xun Niu & Tianshu Zeng & Meixia Lu & Lulu Chen, 2015. "Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis," PLOS ONE, Public Library of Science, vol. 10(10), pages 1-20, October.
    4. Anna Czajkowska & Jadwiga Ambroszkiewicz & Anna Mróz & Katarzyna Witek & Dariusz Nowicki & Łukasz Małek, 2020. "The Effect of the Ultra-Marathon Run at a Distance of 100 Kilometers on the Concentration of Selected Adipokines in Adult Men," IJERPH, MDPI, vol. 17(12), pages 1-11, June.
    5. Kinga Humińska-Lisowska & Jan Mieszkowski & Andrzej Kochanowicz & Aleksandra Bojarczuk & Bartłomiej Niespodziński & Paulina Brzezińska & Błażej Stankiewicz & Monika Michałowska-Sawczyn & Anna Grzywacz, 2022. "Implications of Adipose Tissue Content for Changes in Serum Levels of Exercise-Induced Adipokines: A Quasi-Experimental Study," IJERPH, MDPI, vol. 19(14), pages 1-17, July.
    6. Anna Lubkowska & Aleksandra Radecka & Iwona Bryczkowska & Iwona Rotter & Maria Laszczyńska & Wioleta Dudzińska, 2015. "Serum Adiponectin and Leptin Concentrations in Relation to Body Fat Distribution, Hematological Indices and Lipid Profile in Humans," IJERPH, MDPI, vol. 12(9), pages 1-21, September.
    7. Lorena Ortega Moreno & Lucia Salvemini & Christine Mendonca & Massimiliano Copetti & Concetta De Bonis & Salvatore De Cosmo & Alessandro Doria & Vincenzo Trischitta & Claudia Menzaghi, 2015. "Serum Resistin and Glomerular Filtration Rate in Patients with Type 2 Diabetes," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-9, March.
    8. Tahereh Raeisi & Hossein Rezaie & Mina Darand & Akram Taheri & Nazila Garousi & Bahman Razi & Leonardo Roever & Reza Mohseni & Shimels Hussien Mohammed & Shahab Alizadeh, 2021. "Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-18, March.
    9. Xin-Ning Ng & Chi-Chong Tang & Chih-Hsien Wang & Jen-Pi Tsai & Bang-Gee Hsu, 2021. "Positive Correlation of Serum Resistin Level with Peripheral Artery Disease in Patients with Chronic Kidney Disease Stage 3 to 5," IJERPH, MDPI, vol. 18(23), pages 1-8, December.
    10. Zhi Yu & Amélie Vromman & Ngoc Quynh H. Nguyen & Art Schuermans & Linke Li & Thiago Rentz & Tetsushi Nakao & Shamsudheen K. Vellarikkal & Md Mesbah Uddin & Abhishek Niroula & Gabriel Griffin & Michael, 2025. "Human plasma proteomic profile of clonal hematopoiesis," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    11. Sameena Parveen & Yaser Ali Alhazmi, 2022. "Impact of Intermittent Fasting on Metabolic Syndrome and Periodontal Disease—A Suggested Preventive Strategy to Reduce the Public Health Burden," IJERPH, MDPI, vol. 19(21), pages 1-24, November.

    More about this item

    Keywords

    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ags:aesjfr:405204. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: AgEcon Search (email available below). General contact details of provider: https://www.ccsenet.org/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.